{
    "clinical_study": {
        "@rank": "139541", 
        "acronym": "IGRage", 
        "arm_group": [
            {
                "arm_group_label": "Active TB-infected patients", 
                "description": "TB-infected patients with bacteriological and histological evidences"
            }, 
            {
                "arm_group_label": "Non active TB-infected patients (already met TB)", 
                "description": "some of elders have already met M tuberculosis before active antibiotherapy exists"
            }, 
            {
                "arm_group_label": "Non active TB-infected patients (other diagnosis)", 
                "description": "same symptoms than two others groups but an other diagnosis"
            }
        ], 
        "biospec_descr": {
            "textblock": "Blood samples"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Background: Diagnosis and screening for latent tuberculosis in old patients is of special\n      interest in regards of the morbidity-mortality of this disease in that context.\n\n      TB-infection diagnosis based on immunological memory detection can be impaired with age. New\n      blood tests (QFTB-G and T-SPOT.TB) specific for MTB infection have not been evaluated in\n      those old patients.The primary endpoint of this study is the evaluation of the IGRAS for\n      active TB diagnosis in patients above 75 years old."
        }, 
        "brief_title": "Performance of IGRAs for TB Infection Diagnosis in Elderly", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ageing", 
            "Tuberculosis"
        ], 
        "condition_browse": {
            "mesh_term": "Tuberculosis"
        }, 
        "detailed_description": {
            "textblock": "In vitro Interferon Gamma releasing Assay (IGRA) are recommended for LTBI screening as or\n      instead of TST, but there accuracy in those old patients are not known: as immune responses\n      are impaired in elderly and some of them have already met M tuberculosis before active\n      antibiotherapy exists.The aim of this study is to evaluate characteristics of the two\n      commercials tests IGRA T-spot-TB\u00ae and Quantiferon-TB-gold- in tube\u00ae and TST  in old patients\n      with or without active Tuberculosis.\n\n      Principal outcome:\n\n      - 3 tests performance for active TB diagnosis in patients older than 75 years-old\n\n      Secondary outcomes :\n\n        -  concordance between IGRAs.\n\n        -  non-concordant results analysis\n\n        -  concordance of IGRAs results with time of TB-infection\n\n        -  biobank\n\n      Methodology :Diagnostic test performance study"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 75 years, birth before 1935\n\n          -  Consent signed\n\n          -  Inpatient\n\n          -  Suspicion of active Tuberculosis :\n\n               -  1st Phase (till recruitment of 80 patients in the group 2) : all patient tested\n                  for active TB performed\n\n               -  Second Phase (after 1st phase) : all patient treated for active TB\n\n          -  French social right\n\n        Exclusion Criteria:\n\n          -  Tuberculosis disease treatment since 7 days\n\n          -  No 3 months follow-up possible\n\n          -  Immunosuppression"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "75 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with suspected tuberculosis disease"
            }
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01895582", 
            "org_study_id": "P110131", 
            "secondary_id": "2012-A00326-37"
        }, 
        "intervention": {
            "arm_group_label": [
                "Active TB-infected patients", 
                "Non active TB-infected patients (already met TB)", 
                "Non active TB-infected patients (other diagnosis)"
            ], 
            "description": "4 blood tubes of lithium heparinate (5ml) 3 blood tubes of QTF-G-IT (1ml)\n1 blood dry tube  (5ml)", 
            "intervention_name": "Blood samples", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Interferon-gamma", 
                "Interferons"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Ageing", 
            "Tuberculosis", 
            "Interferon gamma releasing tests"
        ], 
        "lastchanged_date": "October 7, 2013", 
        "location": [
            {
                "contact": {
                    "email": "guillaume.breton@psl.aphp.fr", 
                    "last_name": "Guillaume BRETON, MD", 
                    "phone": "33 1 42 16 10 63"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Servive de M\u00e9decine Interne (Pr S. Herson)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "anne.bourgarit-durand@chru-strasbourg.fr", 
                    "last_name": "Anne BOURGARIT, MD, PhD", 
                    "phone": "33 (0) 3 88 11 67 19"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67000"
                    }, 
                    "name": "Service de M\u00e9decine Interne, Diabete et Maladies M\u00e9taboliques"
                }, 
                "investigator": {
                    "last_name": "Anne BOURGARIT, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "3", 
        "official_title": "Mycobacterium Tuberculosis Infection Diagnosis in Patients Above 75 Years Old/ Performance of Interferon Gamma Releasing Assays (IGRA)", 
        "overall_contact": {
            "email": "anne.bourgarit-durand@chru-strasbourg.fr", 
            "last_name": "Anne BOURGARIT, MD, PhD", 
            "phone": "33 (0)3 88 11 67 19"
        }, 
        "overall_official": {
            "affiliation": "Assistance Publique - H\u00f4pitaux de Paris", 
            "last_name": "Guislaine CARCELAIN, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of positive, indeterminate, negative tests in each group", 
            "safety_issue": "No", 
            "time_frame": "month27"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01895582"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Test results in clinical LTBI patients", 
                "safety_issue": "No", 
                "time_frame": "month 27"
            }, 
            {
                "description": "Test results (positive/negative) according to LTBI date", 
                "measure": "Correlation with TB-infection date", 
                "safety_issue": "No", 
                "time_frame": "month 27"
            }, 
            {
                "measure": "Blood samples collection in order to test new hypothesis in patients with non-concordant results", 
                "safety_issue": "No", 
                "time_frame": "month 27"
            }, 
            {
                "measure": "Performance comparison between tests (T-SPOT.TB\u00ae, Quantiferon-Gold-IT\u00ae)", 
                "safety_issue": "No", 
                "time_frame": "month 27"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}